Merck announced results from two Phase 3 studies evaluating MK-1293, Merck’s investigational, follow-on biologic* insulin glargine candidate for the treatment...
Read moreSanofi announced the presentation of the results of the pivotal Phase 3 LixiLan-O and LixiLan-L clinical trials with the...
Read moreViiV Healthcare announced that the US FDA has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg...
Read moreBiogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being...
Read moreAlexion Pharmaceuticals, Inc announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris®) in patients...
Read moreNatco Pharma Limited announced that its marketing partner, Mylan Inc has received a tentative approval for its Abbreviated New Drug...
Read more
Visionary, up to $2 billion multi-year alliance to focus on development of new gene therapy and gene editing technologies and...
Read more
CPhI& P-MEC China will be held in Shanghai New International Expo Center on June 21-23, 2016.Bearing 15-year trust of the...
Read moreThree Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated Drug DiscoveryAstellas Pharma Inc ,...
Read moreBardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a Phase II Clinical Study in...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
